Healthcare & Pharmaceuticals News
More newsGlobal trends around compounded GLP 1 medicines and SAHPRA’s emerging response
Compounded Glucagon-like peptide 1 (GLP 1) medicines have surged worldwide as demand for weight loss and diabetes treatments continues to outstrip supply. These compounded versions often include modified formulations and added vitamins, or are manufactured outside regulated supply chains, making them significantly different from approved registered products.
Draft Regulations relating to the processing of data subjects' health or sex life by certain responsible parties in terms of Section 112(2)(c) of the Protection of Personal Information Act published on 26 September
The Information Regulator of South Africa published draft regulations for comment on 26 September 2025 – Regulations Relating to the Processing of Data Subjects' Health or Sex Life by Certain Responsible Parties in terms of Section 112(2)(c) of the Protection of Personal Information Act 4 of 2013 (" POPIA ") (" Draft Regulations "). Comments on the Draft Regulations must be submitted on or before 10th October2025.
The goals, timing and criticisms of the NHI Act
On 15 May 2024, President Cyril Ramaphosa signed the National Health Insurance Bill into law. The National Health Insurance Act 20 of 2023 (NHI Act) marks a pivotal moment in South Africa’s healthcare landscape.